Electroconvulsive Therapy in Brazil After the ""Psychiatric Reform"" A Public Health Problem-Example From a University Service

Nenhuma Miniatura disponível
Citações na Scopus
7
Tipo de produção
article
Data de publicação
2012
Título da Revista
ISSN da Revista
Título do Volume
Editora
LIPPINCOTT WILLIAMS & WILKINS
Citação
JOURNAL OF ECT, v.28, n.3, p.170-173, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objectives: The Brazilian public health system does not provide electroconvulsive therapy (ECT), which is limited to a few academic services. National mental health policies are against ECT. Our objectives were to analyze critically the public policies toward ECT and present the current situation using statistics from the Institute of Psychiatry of the University of Sao Paulo (IPq-HCFMUSP) and summary data from the other 13 ECT services identified in the country. Methods: Data regarding ECT treatment at the IPq-HCFMUSP were collected from January 2009 to June 2010 (demographical, number of sessions, and diagnoses). All the data were analyzed using SPSS 19, Epic Info 2000, and Excel. Results: During this period, 331 patients were treated at IPq-HCFMUSP: 221 (67%) were from Sao Paulo city, 50 (15.2%) from Sao Paulo's metropolitan area, 39 (11.8%) from Sao Paulo's countryside, and 20 (6.1%) from other states; 7352 ECT treatments were delivered-63.0% (4629) devoted entirely via the public health system (although not funded by the federal government); the main diagnoses were a mood disorder in 86.4% and schizophrenia in 7.3% of the cases. Conclusions: There is an important lack of public assistance for ECT, affecting mainly the poor and severely ill patients. The university services are overcrowded and cannot handle all the referrals. The authors press for changes in the mental health policies.
Palavras-chave
statistics, Brazilian Public Mental Health System, psychiatric reform
Referências
  1. Benadhira R, 2001, ENCEPHALE, V27, P129
  2. Caetano D, 2006, J BRAS PSIQUIATR, V55, P226
  3. Chanpattana W, 2010, J ECT, V26, P5, DOI 10.1097/YCT.0b013e3181a74368
  4. Chung KF, 2003, J ECT, V19, P98, DOI 10.1097/00124509-200306000-00008
  5. de Lima MA, 2010, REV PSIQUIATR CLIN, V37, P85
  6. Dukakis K., 2006, SHOCK HEALING POWER
  7. Faedda GL, 2010, J AFFECT DISORDERS, V120, P12, DOI 10.1016/j.jad.2009.01.023
  8. Fink M, 1997, MOD PROBL PHARM, V25, P203, DOI 10.1159/000061669
  9. Fink M, 2007, J ECT, V23, P215
  10. HERMANN RC, 1995, AM J PSYCHIAT, V152, P869
  11. Lovisi GM, 2003, SOC PSYCH PSYCH EPID, V38, P493, DOI 10.1007/s00127-003-0666-8
  12. McCall WV, 2001, INT J NEUROPSYCHOPH, V4, P315
  13. Oral ET, 2008, NEUROENDOCRINOL LETT, V29, P11
  14. Pastore DL, 2008, REV PSIQUIATR RIO GD, V30, P175
  15. Reisner AD, 2003, NEUROPSYCHOL REV, V13, P199, DOI 10.1023/B:NERV.0000009484.76564.58
  16. Rosa MA, 2007, J ECT, V23, P224
  17. Salleh MA, 2006, REV PSIQ CLIN, V33, P262
  18. Schlaepfer TE, 2010, WORLD J BIOL PSYCHIA, V11, P2, DOI 10.3109/15622970903170835
  19. Taborda JG, 2008, REV PSIQUIATR HOSP J, V21, P164